When discussing photobiomodulation, most conversations focus on wavelength. Questions about 660 nm versus 850 nm, red light versus near-infrared light, or LED versus laser technology often dominate the discussion.

Wavelength selection is important. But it is only one part of the equation.

A device can use the right wavelength and still fail to deliver meaningful results if the dose is incorrect. This is where Joules per cm² becomes critical. Also known as energy density or fluence, Joules per cm² is one of the most important parameters in light therapy.

For brands developing photobiomodulation devices, understanding dosing is essential. It influences performance, safety, treatment time, user experience and, ultimately, the credibility of the product.

For a deeper explanation of how wavelength selection influences tissue depth and application, read Red Light vs Near-Infrared (NIR): When to Use Which, and Why.

What does Joules per cm² mean?

Joules per cm² describes how much light energy is delivered to a specific area of tissue.

In simple terms, it tells you how much energy reaches one square centimetre of the treatment surface during a session. This makes it different from wavelength, which describes the type of light being used.

A basic way to understand it is this: wavelength influences how light interacts with and penetrates tissue, while dose describes how much energy is applied.

The basic calculation is:

Dose in J/cm² = Irradiance in W/cm² × Treatment time in seconds

Because one watt equals one joule per second, a device delivering 0.05 W/cm² for 200 seconds produces an applied dose of 10 J/cm².

Joules per cm² is influenced by several factors, including power output, treatment time, treatment distance and the size of the treatment area. A high-powered device used for a short period may deliver a similar dose to a lower-powered device used for longer.

That is why two devices using the same wavelength can produce very different treatment conditions.

Why dosing matters in photobiomodulation

Many people assume that more light automatically means better results.

In photobiomodulation, that is not how it works.

PBM commonly demonstrates a principle known as the biphasic dose response. This means biological effects may occur within a particular treatment range. Too little energy may not produce a meaningful response. Increasing the dose beyond the useful range may lead to diminishing results rather than greater benefits.

The goal is not to deliver as much light as possible.

The goal is to deliver an appropriate amount of energy to the intended tissue for the intended application.

This principle applies across many PBM use cases. A wound-focused device, for example, requires a different dosing strategy from a facial skincare mask or a transcranial wearable.

These application-specific mechanisms are explored further in:

• Photobiomodulation for Wound Healing: Accelerating Recovery at a Cellular Level
• Photobiomodulation for Recovery and Pain Relief: How Light Supports Healing
• Photobiomodulation for Brain Health: How Light Supports Cognitive Function
• Photobiomodulation and Anti-Aging: Supporting Skin Health from Within

The relationship between power and time

One of the most common misconceptions in the light therapy industry is that higher power automatically means a better device.

Power matters, but only when understood in relation to time and treatment area.

A device with lower irradiance can still deliver the intended energy dose when the treatment time is long enough. A higher-powered device may deliver the same applied dose in less time.

Neither approach is automatically better.

Higher irradiance may shorten the session, but it can also introduce challenges around heat, comfort, battery capacity, uniformity and safety. Lower irradiance may be easier to manage but require a session that is too long for the intended user experience.

What matters is whether the combination of output and treatment time is appropriate for the biological target.

A facial beauty device does not need the same dose strategy as a recovery panel for muscles and joints. A brain-focused PBM device requires a different approach again because the treatment depth, placement and safety considerations are different.

Dosing must therefore be designed around the intended application rather than copied from another device category.

Why tissue depth affects dosing

The optimal applied dose is not the same for every tissue.

Light loses intensity as it travels through the body. Skin, blood, fat, hair, connective tissue and muscle all absorb or scatter part of the energy. The amount displayed in a device specification is therefore not necessarily the amount that reaches the biological target.

A skincare device designed for facial rejuvenation primarily targets superficial tissue. A recovery product may need to deliver light towards muscles, tendons or joints. A gut-focused or brain-wellness device introduces even more complex optical and anatomical considerations.

This is where wavelength and dose must work together.

Red light is often used for skin and superficial tissues, while near-infrared light is generally better suited to deeper targets. However, wavelength alone does not guarantee performance. The applied energy, treatment geometry and consistency of delivery still need to be engineered correctly.

The cellular mechanism behind these applications is explained in Photobiomodulation and Mitochondrial Health: The Foundation of PBM.

Applied dose is not the same as absorbed dose

Most device specifications describe the light energy applied at the surface.

That is not necessarily the same as the energy absorbed by the target tissue.

Part of the light may be reflected by the skin. Another portion is absorbed by superficial tissue, blood and other structures before reaching the intended depth. Hair, treatment angle, distance and the fit of a wearable can further influence delivery.

This distinction becomes especially important for deep-tissue and transcranial applications.

Manufacturers therefore need to be clear about what a dosing figure represents:

• Output at the LED
• Irradiance at a defined distance
• Applied dose at the skin
• Estimated energy reaching the target
• Absorbed dose within the target tissue

These values should not be treated as interchangeable.

Why device specifications can be misleading

Many light therapy products promote impressive technical claims. High wattage, large LED counts and strong output figures can look convincing from a marketing perspective.

But these numbers do not always tell the full story.

A large LED count does not automatically produce better dosing. A powerful device does not automatically deliver a useful energy density. A bright visible glow also says little about how much therapeutic energy reaches the target tissue.

More useful questions include:

• What is the irradiance at the actual treatment distance?
• How much energy is applied during one complete session?
• Is the output measured across the entire treatment area?
• How uniform is the distribution of light?
• Does output remain stable as the device becomes warmer?
• Is the dose appropriate for the intended application?

These questions are becoming increasingly important as buyers become more informed and professional markets demand stronger technical documentation.

For brands, transparent and well-engineered specifications are no longer optional. They are becoming a core part of product credibility.

Finding the therapeutic window

The therapeutic window is one of the most important concepts in photobiomodulation.

It refers to the range in which an applied dose is sufficient to stimulate the intended biological response without unnecessarily increasing exposure.

This range depends on several factors:

• Wavelength
• Tissue type
• Treatment depth
• Treatment objective
• Irradiance
• Session frequency
• Continuous or pulsed delivery
• User characteristics

A dose that works well for skin rejuvenation may not be suitable for muscle recovery. A protocol designed for pain relief may not be appropriate for oral care, eye health or brain wellness.

This is why strong PBM product development starts with the intended use.

The treatment protocol should not be added after the device has been engineered. It should be developed alongside the LEDs, optics, electronics, thermal controls, safety systems and user experience.

Measuring dose under real treatment conditions

Nominal LED output does not provide enough information to validate a finished product.

Irradiance should be measured where the tissue will actually be positioned during treatment. For a panel, that may mean testing at multiple distances. For a mask or wearable, it means measuring output at the points where the device sits against or near the body.

Development teams should also evaluate:

• Differences across the treatment area
• LED-to-LED variation
• Battery level and power stability
• Thermal drift during the session
• Timer accuracy
• Pulsing and duty cycle
• Mechanical fit
• Manufacturing tolerances

A device may produce the intended average dose while still delivering too much energy in one area and too little in another. Mapping the full treatment surface is therefore more informative than relying on a single central measurement.

Dosing and product development

For brands entering the light therapy market, dosing strategy directly affects product quality.

It influences how long users need to wear or use the device, how comfortable the treatment feels, how consistently the product performs and how well the device aligns with its intended claims.

During development, teams should consider wavelength selection, irradiance, energy density, treatment duration, coverage area, thermal performance, safety limits and regulatory positioning as one connected system.

This is especially important for products positioned around recovery, pain relief, wound healing, brain health or other medical applications. In these categories, vague protocols and weak specifications can create technical and regulatory problems later in the process.

The wider journey from initial concept to validated manufacturing is explained in From Concept to Product: Inside LTV’s Development Process.

When therapeutic or medical claims are planned, dosing requirements should also be aligned with the regulatory pathway from the start. Understanding FDA Clearance for Light Therapy Devices explains how intended use, classification and performance evidence influence access to the US market.

Treatment time is part of the user experience

The technically correct dose is only valuable when users can follow the protocol consistently.

A 30-minute treatment may be acceptable for a professional system but impractical for a consumer product intended for daily use. A very short session may appear attractive, yet require higher irradiance and more demanding thermal management.

The protocol should therefore balance:

• Biological requirements
• Treatment comfort
• Session duration
• Device weight and fit
• Heat generation
• Battery performance
• Expected frequency of use

This is where user-centred development becomes essential. Why Design Thinking Matters in Light Therapy Product Development explains how biological performance and practical usability need to be developed together.

Why precision matters

Two devices can look almost identical from the outside.

They may use similar LEDs, claim the same wavelengths and recommend similar treatment times.

But when one delivers a controlled and consistent dose while the other does not, the difference in performance can be significant.

This is why photobiomodulation product development requires more than selecting components. It requires an understanding of optical delivery, tissue interaction, biological response and manufacturing consistency.

Precision is what separates a basic LED product from a clinically aligned photobiomodulation system.

The future of personalized light therapy dosing

As the light therapy market matures, dosing will become more sophisticated.

Future devices are likely to move beyond fixed treatment programs towards more adaptive protocols. Connected systems may use treatment history, fit detection, sensor data and user feedback to adjust session timing or recommend predefined programs.

Potential developments include:

• App-controlled treatment schedules
• Position and contact detection
• Adaptive session duration
• Multi-wavelength sequencing
• Sensor-informed recommendations
• AI-assisted protocol selection
• Personalized treatment frequency

This is especially relevant for advanced applications such as cognitive performance, gut–brain support, recovery, circadian health and women’s wellness. These categories require more than generic light exposure. They require carefully defined treatment strategies built around specific biological objectives.

Green Light Photobiomodulation: Exploring the Future of Gut–Brain Support shows how emerging applications may place greater emphasis on timing, consistency and biological signalling.

The relationship between light exposure and daily biological timing is explored further in Light Therapy for Sleep Optimization: Aligning with the Circadian Rhythm.

The next generation of PBM devices will not simply ask which wavelength is best. They will examine how wavelength, dose, timing and treatment frequency work together.

Conclusion

Wavelength influences how light interacts with tissue. Dose determines how much energy is applied during treatment.

Understanding Joules per cm² is essential when developing photobiomodulation devices because energy density directly influences treatment conditions and biological response.

The strongest products are not necessarily the brightest or most powerful. They are the products that deliver a controlled amount of energy, at an appropriate wavelength, to the intended treatment area.

At Light Tree Technology, we develop advanced photobiomodulation devices around scientifically informed dosing strategies, precise wavelength selection and scalable manufacturing processes. From concept development and optical engineering to certification and production, we help brands create light therapy technologies designed for consistent real-world performance.

Looking to develop a scientifically optimized PBM device?

Turn light science into a safe, credible and market-ready product.

Start your project with Light Tree Technology.

‍